Rigel’s clinical-stage R552 is the main asset ... can cross into the brain and may have potential in central nervous system disorders. RIPK1 or receptor-interacting serine/threonine-protein ...

Rigel Pharmaceuticals (RIGL ... The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it ...

(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) Thursday announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and Hetero USA, Inc. resolving ...

SOUTH SAN FRANCISCO, Calif., April 4, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals ...